COPD and Cardiovascular Risk in the Population

NCT ID: NCT00787748

Last Updated: 2012-06-15

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 623 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2006-10-31
• Study Completion Date: 2008-06-30

Brief Summary

The prevalence of chronic obstructive pulmonary disease (COPD) in patients with cardiovascular disease (CVD) is unknown, and whether or not COPD is adequately diagnosed and treated in these patients has not been investigated before.

We hypothesized that the prevalence of COPD would be significantly higher (30%) in patients with CVD than in the general population. Besides, we anticipated that COPD, a potentially treatable CV risk factor, would be undiagnosed in more than 80% of CVD patients.

Detailed Description

We aim to compare clinical and spirometric data in three groups of individuals. Two of them are participants in an ongoing population-based study (CORSAIB) aimed at investigating the distribution of CVD risk factors in the general population of the Balearic Islands, Spain. The design and full methodological details of the CORSAIB study have been published elsewhere (Rigo F, et al. Rev Clin Espa 2005). A third group will include patients with stable CVD regularly visited at the referral hospital of our community.

Inclusion criteria for the study are male and female individuals, aged 40 to 81 years, residents of the Balearic Islands, and who are willing to participate in this research.

Conditions

Chronic Obstructive Pulmonary Disease; Cardiovascular Disease

Study Design

• Study Time Perspective: CROSS_SECTIONAL

Eligibility Criteria

Inclusion Criteria

• residents of the Balearic Islands
• willing to participate in this research
• able to sign the written consent form

Exclusion Criteria

• none

• Minimum Eligible Age: 40 Years
• Maximum Eligible Age: 81 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Fondo de Investigacion Sanitaria

OTHER

Sponsor Role: collaborator

Cimera

NETWORK

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Fernando Rigo, MD

Role: STUDY_DIRECTOR

Atención Primaria de Mallorca

Alvar Agusti, MD

Role: STUDY_DIRECTOR

Cimera

Locations

CIMERA

Bunola, Balearic Islands, Spain

Countries

Spain

References

Soriano JB, Rigo F, Guerrero D, Yanez A, Forteza JF, Frontera G, Togores B, Agusti A. High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease. Chest. 2010 Feb;137(2):333-40. doi: 10.1378/chest.09-1264. Epub 2009 Sep 25.

Reference Type: RESULT

PMID: 19783666 (View on PubMed)

Other Identifiers

IB-9949

Identifier Type: -

Identifier Source: secondary_id

IB-615/06PI

Identifier Type: -

Identifier Source: secondary_id

PI061228

Identifier Type: -

Identifier Source: org_study_id